Adagrasib shows promising clinical activity in heavily pretreated KRAS-mutated CRC Presented ByDr Jared Weiss, University of North Carolina at Chapel Hill, NC, USA TrialPhase 1/2, KRYSTAL-1 ConferenceESMO 2021 TypePeer-reviewed article 19 November 2021 09:42